Dementia with Lewy bodies (DLB)
Conditions
Interventions
None listed
Sponsors
Graduate School of Osaka University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria for physicians: Attending physicians who are treating DLB patients at the start of the research who also meet any of the following criteria 1) Dementia with Lewy Bodies Society members and physicians of the medical institution to which the member of the group belongs 2) Chief medical adviser/medical adviser of Dementia with Lewy Bodies Support Network or physicians of the medical institution to which the chief medical adviser/medical adviser belongs 3) Physicians who have written review articles or research papers on DLB and physicians of medical institutions to which said physicians belong Inclusion criteria for patients: 1) Patients who meet probable DLB according to the clinical diagnostic criteria for DLB (2017) and are outpatients over the age of 50 who have been treated by their attending physicians for 3 months or longer. 2) Patients who were fully informed about this research in writing and who have given their informed consent in writing at their or their representative's discretion. 3) Patients with caregivers who have given informed consent to participate in this research Inclusion criteria for caregivers 1) Main caregiver (caregiver who primarily takes care of the patient) 2) 20 years of age or older. 3) Caregivers who were fully informed about this research in writing and who have given their informed consent in writing (whether living together or separately with patients)
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients: 1) Patients with Parkinson's disease with dementia [Parkinson's disease dementia (PDD): Defined as a disease in which Parkinsonism appears more than one year before dementia] 2) Patients who have not been followed up by attending physicians for more than 3 months before their informed consent 3) Patients who received other investigational drugs or clinical research drugs within 4 weeks before the start of this research or patients who have not completed other clinical trials or clinical studies at the time of signing their informed consent. 4) Patients judged by attending physicians as inappropriate for this research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient-physician and patient-caregiver match rates for "patient's most inconvenient symptom classification" and caregiver-physician match rates for "caregiver's most inconvenient symptom classification" | — |
Countries
Japan
Contacts
Public ContactManabu Ikeda
Graduate School of Osaka University Department of Psychiatry, Graduate School of Medicine
Outcome results
None listed